Product use issue: FDA reporting patterns
184,493 FDA FAERS reports mention Product use issue. 82,156 reports have a serious outcome flag.
Medicines named as suspect
- Infliximab: 14,557 reports
- Dupilumab: 10,628 reports
- Polyethylene Glycol: 9,535 reports
- Diclofenac: 8,999 reports
- Methotrexate: 8,528 reports
- Rituximab: 7,757 reports
- Adalimumab: 7,272 reports
- Etanercept: 7,200 reports
- Tocilizumab: 6,297 reports
- Cetirizine: 6,287 reports
- Abatacept: 6,254 reports
- Acetaminophen: 6,207 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.